Literature DB >> 16713566

Nontranscriptional regulation of SYK by the coactivator OCA-B is required at multiple stages of B cell development.

Rachael Siegel1, Unkyu Kim, Alina Patke, Xin Yu, Xiaodi Ren, Alexander Tarakhovsky, Robert G Roeder.   

Abstract

OCA-B was originally identified as a nuclear transcriptional coactivator that is essential for antigen-driven immune responses. The later identification of a membrane bound, myristoylated form of OCA-B suggested additional, unique functions in B cell signaling pathways. This study has shown that OCA-B also functions in the pre-B1-to-pre-B2 cell transition and, most surprisingly, that it directly interacts with SYK, a tyrosine kinase critical for pre-BCR and BCR signaling. This unprecedented type of interaction-a transcriptional coactivator with a signaling kinase-occurs in the cytoplasm and directly regulates SYK stability. This study indicates that OCA-B is required for pre-BCR and BCR signaling at multiple stages of B cell development through its nontranscriptional regulation of SYK. Combined with the deregulation of OCA-B target genes, this may help explain the multitude of defects observed in B cell development and immune responses of Oca-b-/- mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16713566     DOI: 10.1016/j.cell.2006.03.036

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  17 in total

1.  Nuclear import of a lipid-modified transcription factor: mobilization of NFAT5 isoform a by osmotic stress.

Authors:  Birgit Eisenhaber; Michaela Sammer; Wai Heng Lua; Wolfgang Benetka; Lai Ling Liew; Weimiao Yu; Hwee Kuan Lee; Manfred Koranda; Frank Eisenhaber; Sharmila Adhikari
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

2.  Proteomic analysis of fatty-acylated proteins in mammalian cells with chemical reporters reveals S-acylation of histone H3 variants.

Authors:  John P Wilson; Anuradha S Raghavan; Yu-Ying Yang; Guillaume Charron; Howard C Hang
Journal:  Mol Cell Proteomics       Date:  2010-11-14       Impact factor: 5.911

Review 3.  Impaired B lymphopoiesis in old age: a role for inflammatory B cells?

Authors:  Richard L Riley
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

4.  No hiding place for BOB inside myeloma.

Authors:  Hans J Stauss
Journal:  Blood       Date:  2017-03-09       Impact factor: 22.113

Review 5.  Enhancer-promoter communication and transcriptional regulation of Igh.

Authors:  Ananda L Roy; Ranjan Sen; Robert G Roeder
Journal:  Trends Immunol       Date:  2011-08-19       Impact factor: 16.687

6.  BOB.1 of the channel catfish, Ictalurus punctatus: not a transcriptional coactivator?

Authors:  Mara L Lennard Richard; Jun-ichi Hikima; Melanie R Wilson; Norman W Miller; Charles Cunningham; Gregory W Warr
Journal:  Mol Immunol       Date:  2008-11-28       Impact factor: 4.407

7.  Drosophila octamer elements and Pdm-1 dictate the coordinated transcription of core histone genes.

Authors:  Mei-Chin Lee; Ling-Ling Toh; Lai-Ping Yaw; Yan Luo
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

8.  BOB.1/OBF.1 controls the balance of TH1 and TH2 immune responses.

Authors:  Cornelia Brunner; Anca Sindrilaru; Irute Girkontaite; Klaus-Dieter Fischer; Cord Sunderkötter; Thomas Wirth
Journal:  EMBO J       Date:  2007-06-14       Impact factor: 11.598

9.  Deregulated Syk inhibits differentiation and induces growth factor-independent proliferation of pre-B cells.

Authors:  Thomas Wossning; Sebastian Herzog; Fabian Köhler; Sonja Meixlsperger; Yogesh Kulathu; Gerhard Mittler; Akihiro Abe; Uta Fuchs; Arndt Borkhardt; Hassan Jumaa
Journal:  J Exp Med       Date:  2006-11-27       Impact factor: 14.307

10.  Enforced expression of the transcriptional coactivator OBF1 impairs B cell differentiation at the earliest stage of development.

Authors:  Alain Bordon; Nabil Bosco; Camille Du Roure; Boris Bartholdy; Hubertus Kohler; Gabriele Matthias; Antonius G Rolink; Patrick Matthias
Journal:  PLoS One       Date:  2008-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.